BlackRock Japan’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-322
Closed -$14K 1507
2015
Q4
$14K Sell
322
-89
-22% -$4.46K ﹤0.01% 1228
2015
Q3
$18K Sell
411
-26
-6% -$1.4K ﹤0.01% 1105
2015
Q2
$23K Sell
437
-739
-63% -$31.5K ﹤0.01% 1183
2015
Q1
$46K Sell
1,176
-102
-8% -$4K ﹤0.01% 1078
2014
Q4
$49K Buy
+1,278
New +$48.8K ﹤0.01% 1102
2014
Q2
Sell
-4,579
Closed -$119K 1438
2014
Q1
$119K Sell
4,579
-1,361
-23% -$32.6K ﹤0.01% 1028
2013
Q4
$129K Sell
5,940
-316
-5% -$6.47K ﹤0.01% 984
2013
Q3
$122K Sell
6,256
-5,813
-48% -$103K ﹤0.01% 979
2013
Q2
$188K Buy
+12,069
New +$194K ﹤0.01% 880

Other funds holding BSTC

BlackRock Japan's BSTC Position: Q1 2016 in Review

BlackRock Japan sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2016, closing a stake of 322 shares — an estimated $14K sold.

BlackRock Japan first reported a position in BSTC in Q2 2013 and held it in 9 quarters. The position peaked at $188K in Q2 2013. 91 funds tracked by Wall St. Rank hold BSTC as of Q1 2016.

  • BlackRock Japan reported no remaining BioSpecifics Technologies Corp. position as of Q1 2016 after selling out during the quarter.
  • BlackRock Japan sold 322 BioSpecifics Technologies Corp. shares in Q1 2016, an estimated $14K.
  • BlackRock Japan first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 9 quarters.
  • BlackRock Japan's BioSpecifics Technologies Corp. position peaked at $188K in Q2 2013.
  • 91 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2016.

Based on BlackRock Japan's 13F filing for Q1 2016, filed 10 May 2016.